COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Arthur Klausner to be a panelist at the 12th Annual Drug Delivery Partnerships Conference in San Diego, CA
News | 01. 21. 2008
